Publications by authors named "Bishop K"

Background: Deaths in Australia and other high-income countries increasingly involve multiple conditions. However, key burden of disease measures typically only use the underlying cause of death (UC). We quantified sex and cause-specific years of life lost (YLL) based on UC compared with a method integrating multiple causes of death.

View Article and Find Full Text PDF

Purpose: Rett syndrome (RTT) is a rare neurodevelopmental disorder that mainly affects girls and women. Trofinetide is approved for the treatment of RTT in adults and children aged ≥2 years. To gain insight into experiences with RTT and effects of trofinetide treatment at different stages of RTT, interviews with caregivers of individuals with RTT were conducted upon their exit from the open-label trofinetide trials.

View Article and Find Full Text PDF

Introduction: Weight-banded trofinetide dosing improved physician- and caregiver-rated efficacy measures and had acceptable tolerability in patients aged 2‒4 years (DAFFODIL study) and 5‒20 years (LAVENDER study) with Rett syndrome (RTT). Selection of weight-banded dosing regimens for these studies was based on population pharmacokinetic (popPK) modeling and exposure simulations. This study applied an updated popPK model to confirm steady-state trofinetide exposures achieved in DAFFODIL patients were within target range.

View Article and Find Full Text PDF

Introduction: Oral trofinetide administered using a body weight-banded dosing regimen was approved in the US for the treatment of Rett syndrome (RTT) in patients aged ≥ 2 years. This approval was principally based on efficacy and safety findings of the phase 3 LAVENDER study in girls and women aged 5-20 years with RTT and extended to younger children aged 2-4 years with supporting data from the DAFFODIL study. Weight-banded dosing regimens were selected based on early clinical population pharmacokinetic (popPK) modeling and different scenario simulations.

View Article and Find Full Text PDF

Anthropogenic mercury (Hg) emissions to the atmosphere have increased the concentration of this potent neurotoxin in terrestrial and aquatic ecosystems. The magnitude of regional variation in atmospheric Hg pollution levels raises questions about the interactions between natural processes and human activities at local and regional scales that are shaping global atmospheric Hg cycling. Peatlands are potentially valuable and widespread records of past atmospheric Hg levels that could help address these questions.

View Article and Find Full Text PDF

Quality measures for social determinants of health (SDOH) have been introduced or proposed in more than 20 federal programs, initiatives, or guidance documents to capture performance, but understanding the scope of work needed to effectively collect and align with these new measurement requirements is still in its early stages. The National Committee for Quality Assurance (NCQA) recently developed the Social Need Screening and Intervention (SNS-E) measure and is currently building 2 new domains of interest: utility insecurity and social connection. Before these domains can be leveraged to drive population health, the feasibility of collecting and reporting on them must be assessed.

View Article and Find Full Text PDF

Background And Objectives: Trofinetide, the first approved treatment for Rett syndrome (RTT), is primarily excreted unchanged in the urine; therefore, it is important to assess the extent to which the exposure is affected in patients with renal impairment. Pharmacokinetic modeling overcomes the challenge of dose finding in phase 1 studies that include special populations where there is the potential for increased exposure to study drug. The objectives of this phase 1 study were to evaluate trofinetide pharmacokinetics, safety, and tolerability in a population with moderate renal impairment and normal renal function.

View Article and Find Full Text PDF

Innovative models of healthcare, such as telehealth, are required to meet the growing demand for orthotic/prosthetic (O&P) services. While O&P users report being very satisfied with telehealth, many clinical facilities have reverted to in-person modes of care as COVID-19 restrictions have eased. As such, there is a disconnect between benefits of telehealth to O&P users, and the clinical services being delivered in-person.

View Article and Find Full Text PDF
Article Synopsis
  • Adolescents aged 10-19 are increasingly affected by HIV, with 140,000 new diagnoses in 2023, yet testing remains low; index testing offers a promising approach by targeting contacts of those already diagnosed.
  • A study of data from 27 USAID-supported PEPFAR programs (FY 2017-2022) revealed that index testing among adolescents nearly doubled, from 147,088 to 291,534, along with an increase in new diagnoses from 3,721 to 10,730.
  • Despite these gains, testing uptake was higher among females than males, especially in older adolescents; there’s a pressing need for targeted strategies to improve testing rates among 15-19 year olds and
View Article and Find Full Text PDF

Tree rings are an emerging atmospheric mercury (Hg) archive. Questions have arisen, though, regarding their mechanistic controls and reliability. Here, we report contrasting tree-ring Hg records in three collocated conifer species: Norway spruce (), Scots pine (), and European larch (), which are from a remote boreal forest.

View Article and Find Full Text PDF

Background: Maintaining balanced blood product ratios during damage control resuscitation (DCR) is independently associated with improved survival. We hypothesized that real-time performance improvement (RT-PI) would increase adherence to DCR best practice.

Study Design And Methods: From December 2020-August 2021, we prospectively used a bedside RT-PI tool to guide DCR in severely injured patients surviving at least 30 min.

View Article and Find Full Text PDF

The purpose of this article is to analyze a sequence of independent bets by modeling it with a convective-diffusion equation (CDE). The approach follows the derivation of the Kelly Criterion (i.e.

View Article and Find Full Text PDF
Article Synopsis
  • Trofinetide was shown to be effective for treating Rett syndrome in a long-term study called LILAC-2, following a shorter study, LAVENDER, confirming its benefits over 32 months.
  • The study included 77 female participants aged 5-22, examining safety through adverse events and efficacy using specific rating scales, with diarrhea and COVID-19 being the most commonly reported side effects.
  • Caregivers expressed high satisfaction with trofinetide, noting significant improvements in their children's symptoms without any new safety issues arising during the extended treatment.
View Article and Find Full Text PDF

Open-top light-sheet (OTLS) microscopy offers rapid 3D imaging of large optically cleared specimens. This enables nondestructive 3D pathology, which provides key advantages over conventional slide-based histology including comprehensive sampling without tissue sectioning/destruction and visualization of diagnostically important 3D structures. With 3D pathology, clinical specimens are often labeled with small-molecule stains that broadly target nucleic acids and proteins, mimicking conventional hematoxylin and eosin (H&E) dyes.

View Article and Find Full Text PDF
Article Synopsis
  • Trofinetide, approved for treating Rett syndrome, showed continued efficacy and safety in the 40-week LILAC extension study following the initial 12-week LAVENDER trial.
  • A total of 154 female participants aged 5-21 received trofinetide, with common side effects including diarrhea and vomiting; diarrhea was the leading cause for treatment withdrawal.
  • Symptoms of Rett syndrome improved over the 40-week period, with no significant difference in safety profiles between LILAC and the previous LAVENDER study.
View Article and Find Full Text PDF

The HIV-1 capsid (CA) protein forms the outer shell of the viral core that is released into the cytoplasm upon infection. CA binds various cellular proteins, including CPSF6, that direct HIV-1 integration into speckle-associated domains in host chromatin. Upon HIV-1 infection, CPSF6 forms puncta in the nucleus.

View Article and Find Full Text PDF

The first case of CWD in a Norwegian red deer was detected by a routine ELISA test and confirmed by western blotting and immunohistochemistry in the brain stem of the animal. Two different western blotting tests were conducted independently in two different laboratories, showing that the red deer glycoprofile was different from the Norwegian CWD reindeer and CWD moose and from North American CWD. The isolate showed nevertheless features similar to the classical BSE (BSE-C) strain.

View Article and Find Full Text PDF

An important provision of the Minamata Convention on Mercury is to monitor and evaluate the effectiveness of the adopted measures and its implementation. Here, we describe for the first time currently available biotic mercury (Hg) data on a global scale to improve the understanding of global efforts to reduce the impact of Hg pollution on people and the environment. Data from the peer-reviewed literature were compiled in the Global Biotic Mercury Synthesis (GBMS) database (>550,000 data points).

View Article and Find Full Text PDF

Introduction: This case report describes the outcomes of a patient with idiopathic pulmonary fibrosis (IPF) treated with manual therapy (MT) in an outpatient physical therapy setting. IPF is a life-threatening interstitial lung disease, often requiring lung transplant for prolonged health related quality of life and survival. There is little literature to support use of MT for IPF.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to identify risk factors for severe COVID-19 hospitalization among children aged 18 and younger by analyzing data from surveillance sites between April 2020 and March 2022
  • - Among 4688 participants, certain risk factors were found: children under 6 months old, those with underlying medical conditions, infections with specific COVID-19 variants, and co-infection with respiratory syncytial virus (RSV) were more likely to be hospitalized
  • - The findings highlight the importance of age and underlying health issues in assessing the risk of severe respiratory illnesses due to COVID-19 in children, suggesting that ongoing surveillance can effectively monitor these risks.
View Article and Find Full Text PDF
Article Synopsis
  • Neuroscience clinical trials often fail, so choosing the right outcomes early on is really important for finding new treatments in mental and brain health.
  • A group called The Outcomes Research Group is trying to create better ways to pick outcomes for these trials to improve the chances of success.
  • This article gives guidelines on how to standardize the process for choosing outcomes in neuroscience research, helping researchers do better work and avoid risks.
View Article and Find Full Text PDF

Significance: In recent years, we and others have developed non-destructive methods to obtain three-dimensional (3D) pathology datasets of clinical biopsies and surgical specimens. For prostate cancer risk stratification (prognostication), standard-of-care Gleason grading is based on examining the morphology of prostate glands in thin 2D sections. This motivates us to perform 3D segmentation of prostate glands in our 3D pathology datasets for the purposes of computational analysis of 3D glandular features that could offer improved prognostic performance.

View Article and Find Full Text PDF
Article Synopsis
  • - Trofinetide was recently approved for treating Rett syndrome based on positive results from the phase 3 LAVENDER study, which allowed for a weight-based dosing approach.
  • - Efficacy endpoints like the Rett Syndrome Behaviour Questionnaire (RSBQ) and Communication and Symbolic Behavior Scales (CSBS-DP-IT) showed significant improvement correlating with higher trofinetide drug exposure.
  • - The analysis confirmed that higher drug exposure within the target range significantly improved symptoms in patients, supporting the established dosing regimen for trofinetide.
View Article and Find Full Text PDF
Article Synopsis
  • * Trofinetide is a medication developed specifically for RTT, recently approved by the FDA for patients aged 2 years and older.
  • * The successful development of trofinetide highlights the importance of collaboration between research institutions, pharmaceutical companies, and patient advocacy groups in creating effective treatments for rare diseases.
View Article and Find Full Text PDF